The trajectory of the erectile dysfunction drug presents a complex picture for investors. While the initial introduction generated massive returns, the expiration of its patent opened the floodgates to cheaper https://socialwebconsult.com/story7140189/viagra-and-big-pharma-a-volatile-investment